Article info
PDFBiochemical genetics
Original article
Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy
- Correspondence to Dr Malte Lenders, Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, University Hospital Muenster, Muenster D-48149, Germany; malte.lenders{at}ukmuenster.de
Citation
Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy
Publication history
- Received January 8, 2019
- Revised March 14, 2019
- Accepted March 19, 2019
- First published April 22, 2019.
Online issue publication
July 26, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.